Northwest Biotherapeutics, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NWBO Nasdaq 8731 http://www.nwbio.com 0.5731 Stock Down -0.0493

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Northwest Biotherapeutics, Inc

ETF’s with exposure to Northwest Biotherapeutics, Inc. : September 27, 2016 - Sep 27th, 2016 2:12 pm
Biotech School: How to Spot Hidden Danger Signs in Clinical Trial Data - Sep 24th, 2016 7:00 pm
NW Bio Presents Updated Data From DCVax®-Direct Phase I Trial At 5th Annual SMi Cancer Vaccines Conference in London - Sep 21st, 2016 5:51 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits - Sep 19th, 2016 10:02 am
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq - Sep 15th, 2016 1:13 pm
ETF’s with exposure to Northwest Biotherapeutics, Inc. : September 13, 2016 - Sep 13th, 2016 2:45 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq - Sep 9th, 2016 1:04 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an - Sep 6th, 2016 1:18 pm
NASDAQ Accepts NW Bio Remediation Plan For Shares and Warrants Previously Issued to Cognate BioServices - Sep 6th, 2016 12:55 pm
ETF’s with exposure to Northwest Biotherapeutics, Inc. : August 29, 2016 - Aug 29th, 2016 3:53 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq - Aug 23rd, 2016 1:28 pm
NORTHWEST BIOTHERAPEUTICS INC Financials - Aug 19th, 2016 5:04 pm
ETF’s with exposure to Northwest Biotherapeutics, Inc. : August 16, 2016 - Aug 16th, 2016 4:31 pm
Northwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 - Aug 15th, 2016 5:59 pm
Short of Cash, Northwest Bio Flirts With Insolvency - Aug 11th, 2016 2:41 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly Report - Aug 9th, 2016 9:13 pm
ETF’s with exposure to Northwest Biotherapeutics, Inc. : August 5, 2016 - Aug 5th, 2016 7:10 pm
NORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an - Jul 11th, 2016 9:26 pm
NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $3.7 MILLION WITH NEW INSTITUTIONAL INVESTORS - Jul 5th, 2016 1:00 pm
NW Bio Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement - Jun 30th, 2016 9:25 pm